chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID-19; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (COVID-19) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Aug-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided.   Treatment information was not  provided.  The patient was looking for some guidance if the patient should take second vaccine 28 days later.
Mom describes patient was "acting high" with headaches and she "couldn't get up". She was not responsive when spoken to. Mom recorded a video. No treatment.
Several hours after shot, partial hearing loss in right ear.  As of 12/6/2021 the sensation is no better.  Increase in tinnitus as well.
Pt received Varicella and Influenza vaccine at 2:00pm within 15-30 mins, pt developed facial angioedema (lips, eyelids), difficulty breathing, facial flushing, hypoxemia and drooling. Pt started on O2 by nasal cannule, given epinephrine 0.15mg IM and Diphenhydramine 55 mg PO X 7. 01/12/07-records received and reviewed.  DC DX: Allergic reaction. Treated overnight  in ER temp 98.9,  Eyelid, tongue swelling with pruitis and SOB. Treated with Solu-Medrol and Benadryl
On 09/15/17, the provider ordered vaccines for a 4 yr. old Well Child Exam. The provider ordered KINRIX, IPOL, MMR, & Varicella. So the Medical Assistant followed order in chart, which gave the patient an extra dose of IPOL, since one is already included in the KINRIX. On 09/16/17, the school nurse called for a copy of shot record and that is when the error was discovered. The MD in the clinic was notified immediately and grandmother(guardian) was called and notified as well. Grandmother denied any redness, swelling, fever, or any other symptoms and stated child was "running around like always".  Grandmother was advised to notify out office of any problems.
My sore throat started immediately following the flu shot and persisted until I got very sick the following week with a virus which included a high temperature, chills, vomiting, weakness, and exhaustion.  The lymph nodes on my left side (same side of injection were very swollen and my armpit was very tender).  After two days of feeling extremely sick, I came down with secondary infections including a lung/bronchial infection, acute sinus infection, and an ear infection (in my left ear).  I went to the doctor for treatment.  Despite being on antiobiotics, I wake up in a cold sweat every night and the tendons in my left arm continue to be very swollen and very painful.  My shoulder aches all the time and it never bothered me until the flu shot with H1N1.
Mother says she saw redness and swelling to left upper arm on 04/13/05 at supper time. She took child to ER. MD in ER gave antibiotic.
fainted as soon as needle w/drawn from arm;  petit mal sz (appeared to be) on exam table (eyes rolled back), pt became stiff & unresponsive EMS called;  pt awakened 2 mins later Bp 120/90;
Itchy rash on whole body. Rash developed roughly 2 days after injection on 3/24. Went to doctor on 4/5 and was prescribed prednisone.
This spontaneous non valid report was received from a nurse and refers to a unspecified number of patient of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates in October 2017 (reported that from 10-OCT-2017 to 12-OCT-2017), the patients were vaccinated with improperly stored doses of PEDVAXHIB (lot # L051124, expiration date: 14-OCT-2018, lot # M046133, expiration date: 26-SEP-2019), PNEUMOVAX 23 (lot # N003997 expiration date: 20-OCT-2018) and GARDASIL 9 (lot # L036301 expiration date: 20-DEC-2017, lot # M028323, expiration date: 26-SEP-2018 and lot # N017686, expiration date: 2-FEB-2020) (for all vaccines doses and route of administration were not reported) for prophylaxis. There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 9 degrees Celsius (C) to 25C (11.4C) for 1 hours. Data logger was involved. Follow-up information has been received from the nurse on 11-JUN-2018. She provided that the temperature excursion took place on 10-OCT-2017. The patient identification information was not readily available. Follow-up information has been received from the nurse on 11-JUN-2018 concerning a patient of unknown age and gender. The patient was vaccinated with GARDASIL 9 (lot # N017686, expiration date: 02-FEB-2020) of temperature excursion which took place on 10-OCT-2017 from 16:32 until 19:02 (maximum temperature 11.4C). No adverse effects were reported. This is one of several reports received from the same reporter. Upon receipt of follow-up information it was determined that this case is valid because the patient's identifier was received. Sender's Comments: US-009507513-1710USA007686.
Onset of pain in bilateral biceps. Unable to abduct more than 10 degrees without severe pain in both arms. Severe pain and limited range of motion lasted several hours, but I have continued to have the same pain, though less severe, in both upper arms, with some decrease in strength of upper extremities.
I had a foggy brain. I'm forgetting stuff, I have impaired vision, dizziness, off balance. I got an MRI done Extremic disorder, fatigue, headaches. Swollen in my legs, extreme dry eye, blurred vision. I have chest pains on and off. I had to see a Neurologist. And I am still under doctors orders. I am now having allergic reactions that I have taken in the past before the vaccine. I went to an ENT doctor. I have to get a psychological test. I have to take a balance test. I have to see a Cardiologist.
Vaccine was expired on 05 May 2022 stored in freezer and taken out of freezer on 06May2022 and was administered on 06 May 2022; 2 expired doses of moderna covid-19 vaccine administered; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine was expired on 05 May 2022 stored in freezer and taken out of freezer on 06May2022 and was administered on 06 May 2022) and EXPIRED PRODUCT ADMINISTERED (2 expired doses of moderna covid-19 vaccine administered) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (2 expired doses of moderna covid-19 vaccine administered). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 05 May 2022 stored in freezer and taken out of freezer on 06May2022 and was administered on 06 May 2022). At the time of the report, PRODUCT STORAGE ERROR (Vaccine was expired on 05 May 2022 stored in freezer and taken out of freezer on 06May2022 and was administered on 06 May 2022) and EXPIRED PRODUCT ADMINISTERED (2 expired doses of moderna covid-19 vaccine administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. It was reported patient received 1st booster. Vials was stored in freezer and taken out of freezer on 06May2022. Vials did not undergone any temperature excursions. No treatment information was reported.
Patient received the varicella vaccine 4/16/08 and 11 days later she had a lesion appear on her L arm.  Came to the doctor on 4/30/08 and lesion was still present.  Chickenpox dx on 43008.
Left upper outer buttocks with decreased SQ tissue--reddening and thinning of skin.
Three weeks after receiving the vaccination I got my menstrual cycle/period. I had a medical procedure called ablation surgery 7 years ago to eliminate my period doe to heavy period flow, cramping and pain. Now 7 years later I am experiencing another period. I have also been experiencing pain in my upper portion of right calf. It feels like someone hit me with a softball and a stinging feeling has persisted since then. I have a obgyn appointment next week to follow up with this issue.
it hurt this year; Initial information received on 08-Dec-2020 regarding this unsolicited valid non-serious social media case from a consumer (patient).   This case involved a patient with unknown demographics who reported it hurt this year (vaccination site pain), while the patient received INFLUENZA VACCINE.  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.    On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site.   On an unknown date, the patient reported it hurt this year (vaccination site pain) (Unknown latency) following the administration of INFLUENZA VACCINE.   Details of laboratory data was not reported.  It was not reported if the patient received a corrective treatment.  The event outcome was reported as unknown for the event, at the time of reporting.  There will be no information available on the batch number for this case.
approx 6 months after 2nd dose developed moderate/severe cheilitis.  Awaiting dermatology consult.  Currently being treated with topical triamcinolone and bactroban.  I wouldn't have connected this to the covid vaccine except a friend of mine who also had the pfizer vaccine developed the same condition.  And I know MIS-C has been similar to kawasaki's and both have varying degrees of severe chapped lips/cheilitis.  Nothing like this has ever happened to me.  Nothing about my routines are new.  No new products or sensitivities to products have been noted.
Cannot Move; Weakness; Fever; Cannot stand up; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Cannot Move), ASTHENIA (Weakness), PYREXIA (Fever) and DYSSTASIA (Cannot stand up) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included LISINOPRIL for Hypertension, HYDROCHLOROTHIAZIDE and SOTALOL HYDROCHLORIDE (SOTALOL [SOTALOL HYDROCHLORIDE]) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (Cannot Move), ASTHENIA (Weakness), PYREXIA (Fever) and DYSSTASIA (Cannot stand up). The patient was treated with PARACETAMOL (TYLENOL) for Mobility decreased, Fever and Difficulty in standing, at an unspecified dose and frequency and VITAMINS NOS for Vitamin supplementation, at an unspecified dose and frequency. At the time of the report, MOBILITY DECREASED (Cannot Move), ASTHENIA (Weakness), PYREXIA (Fever) and DYSSTASIA (Cannot stand up) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient has taken treatment but he didn't find any improvement.
Pruritus started 1/17 through 1/18. 1/19 woke up with edema, erythema, warm to touch and elevated temp 99.6. 1/20 all sx resolved. 1/21 pruritus began again. 1/22 edema, erythema, warm to touch again but afebrile. 1/23 sx resolved.
10 minutes after receiving Pfizer dose patient complained of being Diaphoretic. Onsite EMS was called vitals BP 100/58 HR 56 98% O2. She had test positive for Covid in October 2020. SHe felt better after about 10 minutes & was released to go home.
vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 01-Jul-2020 and the estimated date of delivery was 04-Apr-2021. On 09-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-fifth week of the pregnancy.  On 09-Mar-2021, EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications or treatment details reported.
approx 1/2hr post vax, pt had high pitched cry for 15min;parents stated pt neck & face appeared blotchy & there was redness @ inj site;DPh was given by parent, pt appeared to have recovered 1hr later;
Approximately 2 months later, suffered a severely perforated appendix requiring emergency surgery and 5 days in the hospital
The next day the injection site became inflamed and erythematous, was the size of a half dollar and continued to increase in size.  On 8/13/16 the site was the size of an orange.  She did not experience any signs of anaphylaxis and no difficulty breathing.  Patient is a nurse and is familiar with appropriate steps to take: cold compress, Benadryl, etc.
1 punctured vial exposed to refrigerator temperature range (2-8 C) for "48 hours"; Expired vaccine administered to patient; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) and PRODUCT STORAGE ERROR (1 punctured vial exposed to refrigerator temperature range (2-8 C) for "48 hours") in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (1 punctured vial exposed to refrigerator temperature range (2-8 C) for "48 hours"). In 2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) had resolved. At the time of the report, PRODUCT STORAGE ERROR (1 punctured vial exposed to refrigerator temperature range (2-8 C) for "48 hours") had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication information was reported. No treatment medications were provided.
uticaria, rash over most of body, continuing today, lethargy, weakness, sore throat, body aches, pain especially in hips, joint pain,
This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (dry mouth) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The patient's past medical history included Carcinoma vocal cord (Vocal cords cancer). Concomitant products included VITAMINS NOS for an unknown indication. On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DRY MOUTH (dry mouth). At the time of the report, DRY MOUTH (dry mouth) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information reported. This case was linked to MOD-2021-246777 (Patient Link).
5-6 days after shot, patient developed redness, swelling, itching, warmth at injection site. Patient went to doctor on 9/16/15. MD said left upper arm has infection.
Patient reports numbness in her arm that began after the first dose of the COVID-19 vaccine. She states that it is not continuous but feels it on and off. She is still able to carry out her daily activities.
Covid arm. Swollen, red, warm, itchy spot at the injection site (aprox 3 inches in diameter).    I noticed some swelling on Saturday night that got worse throughout the evening. By Sunday morning the spot was full size started to itch. Sunday afternoon I took an antihistamine (I don't remember which one). Symptoms improved by Monday afternoon (swelling and itching decreased, redness reduced).
Arm swelled up, severe headache, 1 day later he got chest pain and palpitations and blood pressure shot up.  New EKG findings of myocarditis
rush of blood to back of head, when after exercising pain from the back of the head into the chest and neck since 1st shot.
No adverse event; Bivalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) in a 49-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 11-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients).    Concomitant medications were not reported.  Total 51 doses from Lot AS7140C Bivalent doses were administered after the BUD to patients. Treatment medications were not reported.
This spontaneous report was received from a certified nurse assistant refers to a male patient of unknown age. The patient's pertinent medical history and concurrent conditions were not provided. On 24-APR-2015, the patient was vaccinated with the first dose of (Merck) VARIVAX lot number K016127, expiration date 23-SEP-2016 (route was not provided). Concomitant therapy information was not provided. On 24-APR-2015, the patient received an improperly stored first dose of (Merck) VARIVAX. No adverse symptoms were reported. The temperature excursion for (Merck) VARIVAX was supported in-house stability data. At the time of the report, the patient status was unknown. Additional information has been requested.
Dizziness, Myalgia, Fever, lymphadenopathy, fatigue, injection site pain Narrative: Given antibiotics, NSAID on day #5 since vaccine
Sudden death without warning symptoms 4 days after vaccine.  Many medical problems which most likely explain the outcome but spouse feels it is related and it is a new vaccine.  Monitor for pattern?
This spontaneous report as received from a physician who received information from a patient, refers to multiple unspecified patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On unknown dates, the patients were vaccinated with ZOSTAVAX (strength, dose, route and site of administration, lot # and expiry date were not reported). On unknown dates, the patients contracted shingles after receiving ZOSTAVAX. The outcome of event was unknown. The relatedness between the event and ZOSTAVAX was not provided. Additional information has been requested.
headache, cough, productive cough, nonproductive cough, body aches, sinus congestion, nasal congestion, itchy eyes and fatigue. starting 11/5/21
Sore arm; She felt a lump under her neck,  she can't see by looking but she can feel it; Lymph node under her arm swollen at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of NECK MASS (She felt a lump under her neck,  she can't see by looking but she can feel it), PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE LYMPHADENOPATHY (Lymph node under her arm swollen at the injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 immunisation.     Concurrent medical conditions included Type II diabetes mellitus and Hypertension. Concomitant products included METFORMIN for Blood pressure high.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (Lymph node under her arm swollen at the injection site). On 09-Mar-2021, the patient experienced NECK MASS (She felt a lump under her neck,  she can't see by looking but she can feel it). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, NECK MASS (She felt a lump under her neck,  she can't see by looking but she can feel it), PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE LYMPHADENOPATHY (Lymph node under her arm swollen at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: patient reports following up with HCP and states "everything is okay"
This case was reported by a healthcare professional and described the occurrence of discolored area at injection site in a female subject aged 18 or 19 years old who was vaccinated with Hepatitis B vaccine (manufacturer unspecified). On an unspecified date the subject received 2nd dose of Hepatitis B vaccine in an unknown arm (unknown if ENGERIX B or RECOMBIVAX). Within years of vaccination with Hepatitis B vaccine, the subject experienced discolored area at injection site (purplish stain on arm). At the time of reporting the event was resolved (the event went away in less than a week).
Dizzy, almost passed out around Midnight, 11 hours after injection. Called Doctor in am, only had headache. Not seen. No further symptoms.